Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

NCT03453190 is registered in ClinicalTrials.gov with Washington Dermatology Center as lead sponsor.

NCT NCT03453190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis
Lead sponsor
Washington Dermatology Center
Phase
Phase 4
Overall status
Unknown status
Start date
February 25, 2018
Completion date
June 30, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis